JWH-073

JWH-073, an impressive synthetic cannabinoid, has significant research applications. This comprehensive guide will give you all the information that is necessary about JWH073, such as its development, properties chemical, uses, effects and recommended dosage.

Background and Development

JWH-073 belongs to the JWH Series of Synthetic Cannabinoid Compounds, developed by John W. Huffman a distinguished professor and chemist at Clemson. Huffman synthesized these compounds as part of his research to develop novel cannabinoid agonists that could have therapeutic applications. JWH-073 is not approved for medical or human use. However, its unique pharmacological characteristics have attracted the attention of researchers.

Chemical Name and CAS Number

The CAS number for JWH073 is 20898748-8. This number serves as a unique identifier in scientific databases. The IUPAC (International Union of Pure and Applied Chemistry) name for JWH-073 is naphthalen-1-yl-(1-butylindol-3-yl)methanone. This name provides researchers with a standard reference and describes the chemical structure of the compound.

Molecular Formula

The molecular formula of JWH-073 is C23H21NO. This means that it contains 23 atoms of carbon, 21 hydrogen, one atom each for nitrogen and oxygen. It has a molecular mass of 327.43 grams/mol.

Compound Color and Shape

JWH-073 is a powder that appears white or off-white. Its crystalline structure makes it easy to work with and handle during research. Store JWH-073 away from heat, direct sunlight, and in a dry, cool place to maintain its integrity and stability.

JWH-073: Uses and effects

JWH-073 is not approved for human consumption, nor medical use. However, it has been used in scientific research as a potent cannabinoid agonist, especially at CB1 receptors and CB2 receptors. These receptors are essential in many physiological processes such as the regulation of pain, immune system function and mood regulation. JWH-073 is being studied by researchers to better understand the endocannabinoid systems and potential therapeutic benefits from synthetic cannabinoids.

JWH-073 has a high affinity and selectivity towards the CB1 (brain) receptor. The compound mimics the effects of cannabinoids such as THC. These effects can include feelings of euphoria and relaxation, altered perceptions, and an increased appetite. JWH-073 has a lower potency than THC. This can result in milder effects, and potentially fewer adverse side effects.

Dosage and precautions

JWH-073 has been developed as a research chemical, and is not approved for human consumption. It is therefore important to use extreme caution when handling it. Researchers who work with JWH073 must adhere to strict safety protocol, including using personal protective equipment (PPE) and implementing proper ventilation.

In vitro and in vivo, dosages of JWH073 must be determined carefully based on study objectives and conditions. When designing experiments, researchers must also consider the compound’s potency as well as its potential for adverse effects.

JWH-073 has significant research potential. The unique chemical structure, pharmacological profiles, and ease-of-handling make JWH073 an ideal candidate for scientists seeking to better understanding the endocannabinoid systems and potential therapeutic applications of synthesized cannabinoids.